Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 11/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL198057 | 0.82 | ABCB1 (0.50) | ABCB1ALDH1A1MAOAMAOBDPP4 | |
| SCHEMBL23403212 | 0.81 | TSHR (0.54) | MEN1KMT2APOLB | |
| SCHEMBL13467902 | 0.80 | ABCB1 (0.48) | ABCB1ALDH1A1MAOAMAOBDPP4 | |
| SCHEMBL23400266 | 0.79 | PTGS2 (0.60) | ALDH1A1MEN1KMT2ANPSR1POLB | |
| SCHEMBL2109064 | 0.78 | ALDH1A1 (0.63) | ALDH1A1MEN1KMT2AMAOAMAOB | |
| SCHEMBL15550275 | 0.76 | ABCB1 (0.52) | ABCB1ALDH1A1MAOAMAOBDPP4 | |
| SCHEMBL11413133 | 0.75 | DPP4 (0.41) | ALDH1A1MEN1KMT2ANPSR1MAOA | |
| SCHEMBL23403092 | 0.75 | KMT2A (0.53) | KMT2APOLB | |
| SCHEMBL23403170 | 0.74 | CNR1 (0.44) | ALDH1A1MEN1KMT2ANPSR1POLB | |
| SCHEMBL23399646 | 0.73 | PTGS2 (0.56) | ALDH1A1MEN1KMT2ANPSR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718275-B2 | Electroluminescent materials and devices | MERCK PATENT GMBH (DE) | 2010-05-18 | — | — | US | disclosed |
| US-20060035110-A1 | Electroluminescent materials and devices | OLED-T LIMITED (GB) | 2006-02-16 | — | — | US | disclosed |
| EP-1567612-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | ELAM-T Limited (GB) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004050793-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | ELAM-T LIMITED (GB) | 2004-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060035110-A1 | Electroluminescent materials and devices | DNMT1, BMI1, DNMT3L | ABCB1 3212/4885ALDH1A1 204/4885MEN1 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.